Medlab Clinical talks upcoming Phase III NanaBis trial and NanoCelle partnering opportunities

Date:  2021-06-24

In this interview, Dr Sean Hall is interviewed by Proactive's Andrew Scott.

Medlab is focused on achieving regulatory approval for our lead drug candidate NanaBis™ in the shortest time possible.

We have identified multiple revenue-generating partnering opportunities for our NanoCelle® drug delivery platform which can improve the efficacy of multiple medicines and therapeutics.


Tell us what you think login to share your thoughts.